ACADIA Pharmaceuticals

Yahoo Finance • 5 days ago

Stocks Retreat on Higher Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Wednesday closed down -0.28%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.... Full story

Yahoo Finance • 6 days ago

Stocks Pressured as Bond Yields Rise

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.03%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story

Yahoo Finance • 6 days ago

Stocks See Support from Strength in Chip Makers and AI Optimism

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.06%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story

Yahoo Finance • 6 days ago

Lithium Americas, Oracle, Acadia Pharma: Trending Tickers

Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including reports that the Trump administration is pursuing a stake in miner Lithium Americas (LAC), Oracle's (ORCL) goal of raising $15 billion in bond... Full story

Yahoo Finance • 8 days ago

US High Growth Tech Stocks to Watch for Potential Expansion

As the United States stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite posting consecutive weeks of gains, investors are paying close attention to high-growth sectors such as technology.... Full story

Yahoo Finance • 19 days ago

ACADIA Pharmaceuticals Inc. (ACAD) Nears Key Phase 3 Readout in Prader-Willi Syndrome

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. ACADIA Pharmaceuticals Inc. stands second among them. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company that focuses... Full story

Yahoo Finance • 22 days ago

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Emerges as a Top Affordable Growth Stock

In the search for growth stocks that do not have high price tags, many investors use the "Affordable Growth" method. This method looks for firms showing good expansion numbers while keeping fair prices, good earnings, and sound finances, e... Full story

Yahoo Finance • last month

US High Growth Tech Stocks to Watch This August 2025

As of August 2025, the U.S. stock market is experiencing a remarkable upswing, with key indices like the S&P 500 and Dow Jones Industrial Average reaching record highs amid anticipation of a significant inflation report. In this thriving e... Full story

Yahoo Finance • last month

How Investors May Respond To ACADIA Pharmaceuticals (ACAD) Hiring an Industry Veteran for Growth Strategy

On August 25, 2025, Acadia Pharmaceuticals announced the appointment of Konstantina (“Tina”) Katcheves as Senior Vice President, Chief Business and Strategy Officer, bringing her extensive leadership experience from Teva Pharmaceuticals an... Full story

Yahoo Finance • last month

Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer

SAN DIEGO, August 25, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Konstantina ("Tina") Katcheves as Senior Vice President, Chief Business and Strategy Officer. In this role, Tina wil... Full story

Yahoo Finance • last month

Acadia Pharma EVP Schneyer sells $554k in stock

Acadia Pharmaceuticals (NASDAQ:ACAD), a $4.2 billion market cap company that has delivered an impressive 58% return over the past year, reported that Executive Vice President and Chief Financial Officer Mark C. Schneyer sold 22,000 shares... Full story

Yahoo Finance • last month

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Combines Strong Fundamentals with Bullish Technicals for Growth Potential

Combining solid fundamental growth with positive technical patterns can be an effective way to spot stocks with potential gains. This method looks for companies that show increasing revenue and earnings growth while also displaying positiv... Full story

Yahoo Finance • 2 months ago

High Growth Tech Stocks To Watch In The US August 2025

As the U.S. market experiences a mix of record highs and tempered expectations due to recent inflation reports, investors are closely monitoring economic indicators that could influence Federal Reserve policy decisions on interest rates. I... Full story

Yahoo Finance • 2 months ago

Acadia raises 2025 NUPLAZID guidance to $665M–$690M as DAYBUE accelerates community uptake

Earnings Call Insights: ACADIA Pharmaceuticals (ACAD) Q2 2025 MANAGEMENT VIEW * Catherine E. Owen Adams, CEO, stated that "Our second quarter performance reinforces the momentum we're building across all facets of our business from com... Full story

Yahoo Finance • 2 months ago

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Q2 2025 Earnings: Revenue Growth Meets Expectations, EPS Beats Estimates

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD [https://www.chartmill.com/stock/quote/ACAD/profile]) REPORTS Q2 2025 EARNINGS: REVENUE GROWTH MEETS EXPECTATIONS, EPS BEATS ESTIMATES Acadia Pharmaceuticals Inc. released its second-quarter 2025 fi... Full story

Yahoo Finance • 2 months ago

Here are the major earnings after the close Wednesday

Major earnings expected after the bell on Wednesday include: * Realty Income Corporation (O [https://seekingalpha.com/symbol/O]) * Energy Transfer LP (ET [https://seekingalpha.com/symbol/ET]) * Occidental Petroleum Corporation (OXY... Full story

Yahoo Finance • 2 months ago

S&P Futures Gain With Focus on Earnings and Fed Speak

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning as investors digested U.S. President Donald Trump’s latest tariff threats and weak economic data, while shifting t... Full story

Yahoo Finance • 2 months ago

Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer

SAN DIEGO, August 04, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Scott Cenci as Senior Vice President, Chief Information and Data Officer. In this role, Scott will lead Acadia’s dig... Full story

Yahoo Finance • 2 months ago

High Growth Tech Stocks in the US for July 2025

In the last week, the market has been flat, but it is up 16% over the past year with earnings forecast to grow by 15% annually. In this context of steady growth, identifying high-growth tech stocks involves looking for companies that are w... Full story

Yahoo Finance • 2 months ago

High Growth Tech Stocks in the US Market July 2025

Over the last 7 days, the United States market has remained flat, yet it has shown a robust performance with a 17% increase over the past year and earnings forecasted to grow by 15% annually. In this environment of steady growth, identifyi... Full story